New Spectrophotometric Method for the Determination of Bosentan - An Anti-Hypertensive Agent in Pharmaceutical Dosage Forms

A new, simple and sensitive spectrophotometric method in ultraviolet region has been developed for the determination of Bosentan in bulk and in pharmaceutical formulations. Bosentan exhibits absorption maxima at 273 nm with apparent molar absorptivity of 1.3293×104 L/mol.cm in methanol and octane 1-...

Full description

Saved in:
Bibliographic Details
Main Authors: A. Narendra, D. Deepika, M. Mathrusri Annapurna
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:E-Journal of Chemistry
Online Access:http://dx.doi.org/10.1155/2012/359745
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832545378279358464
author A. Narendra
D. Deepika
M. Mathrusri Annapurna
author_facet A. Narendra
D. Deepika
M. Mathrusri Annapurna
author_sort A. Narendra
collection DOAJ
description A new, simple and sensitive spectrophotometric method in ultraviolet region has been developed for the determination of Bosentan in bulk and in pharmaceutical formulations. Bosentan exhibits absorption maxima at 273 nm with apparent molar absorptivity of 1.3293×104 L/mol.cm in methanol and octane 1-sulfonic acid solvent mixture. Beer's law was found to be obeyed in the concentration range of 0.1-100 μg/mL. The method was validated as per the ICH guidelines.
format Article
id doaj-art-83ec81831fef4feb9ea156d277a30a83
institution Kabale University
issn 0973-4945
2090-9810
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series E-Journal of Chemistry
spelling doaj-art-83ec81831fef4feb9ea156d277a30a832025-02-03T07:26:02ZengWileyE-Journal of Chemistry0973-49452090-98102012-01-019270070410.1155/2012/359745New Spectrophotometric Method for the Determination of Bosentan - An Anti-Hypertensive Agent in Pharmaceutical Dosage FormsA. Narendra0D. Deepika1M. Mathrusri Annapurna2Department of Pharmaceutical analysis and Quality Assurance, Roland Institute of Pharmaceutical Sciences, Berhampur, Orissa, IndiaRoyal College of Pharmacy and Health Sciences, Berhampur, Orissa, IndiaGITAM Institute of Pharmacy, GITAM University, Visakhapatnam, IndiaA new, simple and sensitive spectrophotometric method in ultraviolet region has been developed for the determination of Bosentan in bulk and in pharmaceutical formulations. Bosentan exhibits absorption maxima at 273 nm with apparent molar absorptivity of 1.3293×104 L/mol.cm in methanol and octane 1-sulfonic acid solvent mixture. Beer's law was found to be obeyed in the concentration range of 0.1-100 μg/mL. The method was validated as per the ICH guidelines.http://dx.doi.org/10.1155/2012/359745
spellingShingle A. Narendra
D. Deepika
M. Mathrusri Annapurna
New Spectrophotometric Method for the Determination of Bosentan - An Anti-Hypertensive Agent in Pharmaceutical Dosage Forms
E-Journal of Chemistry
title New Spectrophotometric Method for the Determination of Bosentan - An Anti-Hypertensive Agent in Pharmaceutical Dosage Forms
title_full New Spectrophotometric Method for the Determination of Bosentan - An Anti-Hypertensive Agent in Pharmaceutical Dosage Forms
title_fullStr New Spectrophotometric Method for the Determination of Bosentan - An Anti-Hypertensive Agent in Pharmaceutical Dosage Forms
title_full_unstemmed New Spectrophotometric Method for the Determination of Bosentan - An Anti-Hypertensive Agent in Pharmaceutical Dosage Forms
title_short New Spectrophotometric Method for the Determination of Bosentan - An Anti-Hypertensive Agent in Pharmaceutical Dosage Forms
title_sort new spectrophotometric method for the determination of bosentan an anti hypertensive agent in pharmaceutical dosage forms
url http://dx.doi.org/10.1155/2012/359745
work_keys_str_mv AT anarendra newspectrophotometricmethodforthedeterminationofbosentananantihypertensiveagentinpharmaceuticaldosageforms
AT ddeepika newspectrophotometricmethodforthedeterminationofbosentananantihypertensiveagentinpharmaceuticaldosageforms
AT mmathrusriannapurna newspectrophotometricmethodforthedeterminationofbosentananantihypertensiveagentinpharmaceuticaldosageforms